Related Experiment Videos
Child development after maternal tocolysis with beta-sympathomimetic drugs
M Pitzer1, M H Schmidt, G Esser
1Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, P.O. Box 122120, D-68072 Mannheim, Germany. pitzer@as200.zi-mannheim.de
Child Psychiatry and Human Development
|February 24, 2001
Summary
Tocolytic treatment during pregnancy may negatively impact term children's psychiatric and cognitive development. However, preterm infants exposed to tocolysis showed no adverse developmental effects, warranting further research.
Area of Science:
- Perinatal medicine
- Developmental psychology
- Pediatric neurology
Background:
- Tocolytic treatments are used to prolong pregnancy.
- The impact of tocolysis on child neurodevelopment requires further investigation.
- Maternal tocolytic exposure is a potential factor influencing child outcomes.
Purpose of the Study:
- To assess the psycho-social development of children exposed to tocolytic treatment in utero.
- To compare developmental outcomes between term and preterm children exposed to tocolysis.
- To identify potential risks associated with maternal tocolytic use.
Main Methods:
- Longitudinal assessment of psycho-social development at ages 2, 4.5, and 8 years.
- Comparison of children with maternal tocolytic exposure versus control groups.
- Evaluation of cognitive, motor, and psychiatric outcomes.
Main Results:
- Term children exposed to tocolysis exhibited increased psychiatric disorders.
- Term children exposed to tocolysis demonstrated poorer cognitive and motor performance.
- No adverse developmental impact of tocolysis was observed in preterm children.
Conclusions:
- Maternal tocolytic treatment may pose risks to neurodevelopment in term infants.
- Preterm infants may be resilient to the developmental effects of tocolysis.
- Further prospective studies are needed to confirm these findings and elucidate mechanisms.